National Institute on Drug Abuse; Notice of Closed Meetings, 25099 [05-9509]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 91 / Thursday, May 12, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Initial Review Group;
Medication Development Research
Subcommittee.
Date: June 6, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Paul A. Coulis, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6101 Executive Boulevard, Suite 220,
Bethesda, MD 20892–8401. (301) 443–2105.
Name of Committee: National Institute on
Drug Abuse Initial Review Group; Health
Services Research Subcommittee.
Date: June 7–8, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Mark R. Green, PhD,
Deputy Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401. (301)
435–1431.
Name of Committee: National Institute on
Drug Abuse Initial Review Group; Treatment
Research Subcommittee.
Date: June 7–8, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kesinee Nimit, MD, Health
Scientist Administrator, Office of Extramural
Affairs, National Institute on Drug Abuse,
NIH, DHHS, Room 220, MSC 8401, 6101
VerDate jul<14>2003
19:04 May 11, 2005
Jkt 205001
Executive Boulevard, Bethesda, MD 20892–
8401. (301) 435–1432.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Member
Conflict A.
Date: June 7, 2005.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401. (301)
435–1388.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Member
Conflict B.
Date: June 8, 2005.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401. (301)
435–1388.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Secondary Data Analysis of NESARC and
NSPY Studies.
Date: July 7–8, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Mark Swieter, PhD, Chief,
Training and Special Projects Review Branch,
Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6101
Executive Boulevard Suite 220, Bethesda,
MD 20892–8401. (301) 435–1389.
ms80x@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Centers
Review Meeting.
Date: July 12, 2005.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Rita Liu, PhD, Associate
Director, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 212, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401. (301)
435–1388.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Training
and Career Development Subcommittee.
Date: July 19–21, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
25099
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institutes of
Drug Abuse, NIH, DHHS, 6101 Executive
Boulevard, Room 220, MSC 8401, Bethesda,
MD 20892–8401. (301) 451–4530.
el6r@nih.gov.
(Catalogue of Federal Domestic Assistant
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health, HHS)
Dated: May 6, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9509 Filed 5–11–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel; IAIMS.
Date: June 10, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Hua-Chuan Sim, MD,
Scientific Review Administrator, National
Library of Medicine, Extramural Programs,
6705 Rockledge Drive, Suite 301, Bethesda,
MD 20892.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
E:\FR\FM\12MYN1.SGM
12MYN1
]]>Agencies
[Federal Register Volume 70, Number 91 (Thursday, May 12, 2005)]
[Notices]
[Page 25099]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9509]
[[Page 25099]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Initial
Review Group; Medication Development Research Subcommittee.
Date: June 6, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Paul A. Coulis, PhD, Health Scientist
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health, DHHS, 6101 Executive
Boulevard, Suite 220, Bethesda, MD 20892-8401. (301) 443-2105.
Name of Committee: National Institute on Drug Abuse Initial
Review Group; Health Services Research Subcommittee.
Date: June 7-8, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Mark R. Green, PhD, Deputy Director, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1431.
Name of Committee: National Institute on Drug Abuse Initial
Review Group; Treatment Research Subcommittee.
Date: June 7-8, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Kesinee Nimit, MD, Health Scientist
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard,
Bethesda, MD 20892-8401. (301) 435-1432.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Member Conflict A.
Date: June 7, 2005.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rita Liu, PhD, Associate Director, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1388.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Member Conflict B.
Date: June 8, 2005.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rita Liu, PhD, Associate Director, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1388.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Secondary Data Analysis of NESARC and NSPY Studies.
Date: July 7-8, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC
20037.
Contact Person: Mark Swieter, PhD, Chief, Training and Special
Projects Review Branch, Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6101 Executive Boulevard Suite
220, Bethesda, MD 20892-8401. (301) 435-1389. ms80x@nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Centers Review Meeting.
Date: July 12, 2005.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes
Street, Arlington, VA 22202.
Contact Person: Rita Liu, PhD, Associate Director, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1388.
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Training and Career Development Subcommittee.
Date: July 19-21, 2005.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Eliane Lazar-Wesley, PhD, Health Scientist
Administrator, Office of Extramural Affairs, National Institutes of
Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Room 220, MSC 8401,
Bethesda, MD 20892-8401. (301) 451-4530. el6r@nih.gov.
(Catalogue of Federal Domestic Assistant Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse Research Programs, National Institutes of Health,
HHS)
Dated: May 6, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-9509 Filed 5-11-05; 8:45 am]
BILLING CODE 4140-01-M
